Search research articles
Contact Us
Filters
Showing results (701-710 of 715) with videos related to
Page
of 72
Sort By:
British Journal of Haematology
|
November 22, 2020
Second primary malignancy in myelofibrosis patients treated with ruxolitinib
Nicola Polverelli, Elena M Elli, Elisabetta Abruzzese, et al.
Science Translational Medicine
|
March 11, 2021
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma
Priya Kumthekar, Caroline H Ko, Tatjana Paunesku, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2025
Ziftomenib in Relapsed or Refractory <i>NPM1</i>-Mutated AML
Eunice S Wang, Pau Montesinos, James Foran, et al.
Blood
|
October 25, 2021
PLCG1 is required for AML1-ETO leukemia stem cell self-renewal
Tina M Schnoeder, Adrian Schwarzer, Ashok Kumar Jayavelu, et al.
Cancer
|
May 12, 2026
Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study
Francesca Palandri, Monia Marchetti, Elena M Elli, et al.
Blood
|
October 27, 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML
Viktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, et al.
Blood Cancer Journal
|
May 3, 2023
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib
Francesca Palandri, Elena M Elli, Giuseppe Auteri, et al.
Annals of Hematology
|
March 4, 2024
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
Jean-Jacques Kiladjian, Francisca Ferrer Marin, Haifa Kathrin Al-Ali, et al.
Science Translational Medicine
|
February 23, 2018
Oncogenic JAK2<sup>V617F</sup> causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms
Alessandro Prestipino, Alica J Emhardt, Konrad Aumann, et al.
NPJ Digital Medicine
|
March 28, 2025
Leveraging electronic medical records to evaluate a computerized decision support system for staphylococcus bacteremia
Julia Palm, Ssuhir Alaid, Danny Ammon, et al.
Page
of 72
Search research articles
Search
Showing results (701-710 of 715) with videos related to
Sort By:
Page
of 72
British Journal of Haematology
|
November 22, 2020
Second primary malignancy in myelofibrosis patients treated with ruxolitinib
Nicola Polverelli, Elena M Elli, Elisabetta Abruzzese, et al.
Science Translational Medicine
|
March 11, 2021
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma
Priya Kumthekar, Caroline H Ko, Tatjana Paunesku, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2025
Ziftomenib in Relapsed or Refractory <i>NPM1</i>-Mutated AML
Eunice S Wang, Pau Montesinos, James Foran, et al.
Blood
|
October 25, 2021
PLCG1 is required for AML1-ETO leukemia stem cell self-renewal
Tina M Schnoeder, Adrian Schwarzer, Ashok Kumar Jayavelu, et al.
Cancer
|
May 12, 2026
Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study
Francesca Palandri, Monia Marchetti, Elena M Elli, et al.
Blood
|
October 27, 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML
Viktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, et al.
Blood Cancer Journal
|
May 3, 2023
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib
Francesca Palandri, Elena M Elli, Giuseppe Auteri, et al.
Annals of Hematology
|
March 4, 2024
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
Jean-Jacques Kiladjian, Francisca Ferrer Marin, Haifa Kathrin Al-Ali, et al.
Science Translational Medicine
|
February 23, 2018
Oncogenic JAK2<sup>V617F</sup> causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms
Alessandro Prestipino, Alica J Emhardt, Konrad Aumann, et al.
NPJ Digital Medicine
|
March 28, 2025
Leveraging electronic medical records to evaluate a computerized decision support system for staphylococcus bacteremia
Julia Palm, Ssuhir Alaid, Danny Ammon, et al.
Page
of 72